Sevoflurane



Indications and Reactions:

Role Indications Reactions
Primary
Anaesthesia 15.7%
Drug Use For Unknown Indication 15.6%
Product Used For Unknown Indication 14.3%
Maintenance Of Anaesthesia 11.6%
Induction Of Anaesthesia 11.4%
General Anaesthesia 8.6%
Prophylaxis 3.4%
Premedication 3.4%
Induction And Maintenance Of Anaesthesia 2.8%
Neoplasm Malignant 2.1%
Analgesic Therapy 1.5%
Arrhythmia 1.5%
Laryngospasm 1.5%
Muscle Relaxant Therapy 1.3%
Surgery 1.2%
Sedation 1.0%
Hypotonia 1.0%
Blood Pressure Management 0.8%
Asthma 0.7%
Drug Exposure During Pregnancy 0.7%
Hyperthermia 13.4%
Rhabdomyolysis 8.7%
Unwanted Awareness During Anaesthesia 8.7%
Vomiting 6.8%
Pneumonia 6.1%
Electrocardiogram Qt Prolonged 5.5%
Anaesthetic Complication Neurological 5.0%
Torsade De Pointes 4.8%
Ventricular Tachycardia 4.8%
Ventricular Fibrillation 4.5%
Hypotension 3.7%
Nausea 3.7%
Cardiac Arrest 3.5%
Hyperthermia Malignant 3.5%
Pulmonary Oedema 3.5%
Staring 3.4%
Hypoxia 2.9%
Drug Exposure During Pregnancy 2.6%
Myocardial Infarction 2.4%
Oxygen Saturation Decreased 2.4%
Secondary
Maintenance Of Anaesthesia 17.2%
Anaesthesia 14.5%
General Anaesthesia 14.4%
Product Used For Unknown Indication 11.8%
Induction Of Anaesthesia 11.6%
Drug Use For Unknown Indication 5.6%
Prophylaxis 3.9%
Premedication 3.6%
Induction And Maintenance Of Anaesthesia 2.9%
Arrhythmia 1.8%
Surgery 1.8%
Laryngospasm 1.8%
Neoplasm Malignant 1.7%
Analgesic Therapy 1.2%
Muscle Relaxant Therapy 1.1%
Anaesthesia Procedure 1.1%
Sedation 1.0%
Epidural Anaesthesia 1.0%
Hypertension 1.0%
Local Anaesthesia 0.9%
Low Birth Weight Baby 22.8%
Hyperthermia 9.1%
Unwanted Awareness During Anaesthesia 8.7%
Ventricular Tachycardia 8.1%
Delayed Recovery From Anaesthesia 6.2%
Pneumonia 6.0%
Ventricular Fibrillation 4.7%
Vomiting 4.2%
Rhabdomyolysis 4.0%
Torsade De Pointes 3.9%
Nausea 3.7%
Tachycardia 2.9%
Hypotension 2.5%
Stress Cardiomyopathy 2.5%
Hypoxia 2.3%
Cardiac Arrest 2.0%
Anaphylactic Shock 1.8%
Pulmonary Oedema 1.7%
Sinus Tachycardia 1.5%
Myotonia 1.3%
Concomitant
Induction Of Anaesthesia 17.4%
Maintenance Of Anaesthesia 13.8%
Product Used For Unknown Indication 13.3%
Anaesthesia 12.9%
General Anaesthesia 11.2%
Drug Use For Unknown Indication 8.0%
Hypertension 3.1%
Epidural Anaesthesia 2.5%
Induction And Maintenance Of Anaesthesia 2.1%
Analgesic Therapy 2.0%
Postoperative Analgesia 1.8%
Anaesthesia Procedure 1.8%
Pain 1.6%
Neuromuscular Blockade Reversal 1.5%
Prophylaxis Of Nausea And Vomiting 1.3%
Local Anaesthesia 1.2%
Neuromuscular Blocking Therapy 1.2%
Prophylaxis 1.2%
Anaesthetic Premedication 1.1%
Hypotension 1.1%
Tachycardia 9.4%
Ventricular Tachycardia 8.2%
Pulmonary Oedema 6.1%
Tremor 6.1%
Respiratory Depression 5.8%
Respiratory Failure 5.5%
Anaphylactic Shock 5.2%
Unresponsive To Stimuli 5.2%
Cardiac Arrest 4.8%
Serotonin Syndrome 4.8%
Anaphylactic Reaction 4.2%
Drug Ineffective 4.2%
Drug Interaction 4.2%
Migraine 3.9%
Neuromuscular Block Prolonged 3.9%
Oxygen Saturation Decreased 3.9%
Pneumonia Aspiration 3.9%
Urticaria 3.9%
Renal Failure Acute 3.3%
Rhabdomyolysis 3.3%
Interacting
General Anaesthesia 34.3%
Osteotomy 10.2%
Induction Of Anaesthesia 8.3%
Neuralgia 5.9%
Anaesthesia 5.2%
Hypertension 5.2%
Pain 4.6%
Maintenance Of Anaesthesia 4.3%
Varicose Vein Operation 4.3%
Product Used For Unknown Indication 3.7%
Tachycardia 3.7%
Musculoskeletal Pain 2.8%
Sedation 1.9%
Analgesia 0.9%
Blood Pressure Fluctuation 0.9%
Prophylaxis Of Nausea And Vomiting 0.9%
Thyroglossal Cyst Excision 0.9%
Analgesic Therapy 0.6%
Arginase Increased 0.6%
Arrhythmia 0.6%
Sinus Tachycardia 40.9%
Drug Interaction 9.1%
Cardiac Arrest 6.8%
Myotonia 4.5%
No Adverse Event 4.5%
Renal Failure Acute 4.5%
Supraventricular Extrasystoles 4.5%
Arrhythmia 2.3%
Hypotension 2.3%
Hypoxia 2.3%
Obstructive Airways Disorder 2.3%
Renal Tubular Necrosis 2.3%
Respiratory Depression 2.3%
Respiratory Paralysis 2.3%
Salivary Gland Neoplasm 2.3%
Tenotomy 2.3%
Ventricular Fibrillation 2.3%
Ventricular Tachycardia 2.3%